Macrophage Migration Inhibitory Factor in Early and Late Neonatal Sepsis

Background: Neonatal Sepsis (NS) is a major health risk for newborns, particularly those bornpreterm, and is a primary contributor to morbidity. Research has identified Macrophage Migration Inhibitory Factor (MIF) as a key player in the devel-opment of sepsis and other immunerelated diseases. Aim of Study: The current research aimed to quantify MIF-concentrations in neonates with early and late-onset sepsis and correlate its levels with other key clinical and laboratory indi-cators in comparison to non-septic neonates. Patients and Methods: Thiscross-sectional research was conducted from March to September 2023 and involved 32 neonates with Early-Onset (EONS, n=16) and Late-Onset (LONS, n=16) neonatal sepsis, confirmed by positive blood cultures, compared to another 32 non-septic neonates (con-trols), matched for age and gender. All neonates underwent ba-sic laboratory tests, and MIF levels were assessed using ELISA. Results: The mean levels of MIF were significantly high-er in both early-onset (169.11±51.88ng/ml) and late-onset (150.6±57.43ng/ml) neonatal sepsis groups, in comparison with the non-septic group (41.97±17.5ng/ml, p-value=0.000). The two groups with sepsisexhibited comparable MIF values. A cutoffvalue >66.7ng/ml for MIF levels was determined to dis-criminate between septic and non-septic neonates with (100% sensitivity; 96.87% specificity; positive predictive value: 97%; negative predictive value: 100%; AUC: 0.997). Furthermore, MIF levels were negatively correlated with absolute lympho-cytic count, PH level in early-onset and random blood glucose in late-onset neonatal sepsis groups. Conclusion: MIF could be an excellent and early diagnos-tic marker for NS even in preterm neonates. Further studies are needed to correlate MIF levels with severity of neonatal sep-sis and compare the diagnostic and prognostic utility of Mac-rophage Migration Inhibitory Factor with other inflammatory biomarkers, like procalcitonin and C-Reactive Protein (CRP).

Authors

Institutions

Publication Details

Journal
The Medical Journal of Cairo University/˜The œMedical Journal of Cairo University
Published
2025-03-01
DOI
https://doi.org/10.21608/mjcu.2025.423300
Primary Topic
Macrophage Migration Inhibitory Factor
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Macrophage Migration Inhibitory Factor in Early and Late Neonatal Sepsis

Mootaz Shousha
The Medical Journal of Cairo University/˜The œMedical Journal of Cairo University
Macrophage Migration Inhibitory Factor
article

Macrophage Migration Inhibitory Factor in Early and Late Neonatal Sepsis

Mootaz Shousha
article en

Abstract

Background: Neonatal Sepsis (NS) is a major health risk for newborns, particularly those bornpreterm, and is a primary contributor to morbidity. Research has identified Macrophage Migration Inhibitory Factor (MIF) as a key player in the devel-opment of sepsis and other immunerelated diseases. Aim of Study: The current research aimed to quantify MIF-concentrations in neonates with early and late-onset sepsis and correlate its levels with other key clinical and laboratory indi-cators in comparison to non-septic neonates. Patients and Methods: Thiscross-sectional research was conducted from March to September 2023 and involved 32 neonates with Early-Onset (EONS, n=16) and Late-Onset (LONS, n=16) neonatal sepsis, confirmed by positive blood cultures, compared to another 32 non-septic neonates (con-trols), matched for age and gender. All neonates underwent ba-sic laboratory tests, and MIF levels were assessed using ELISA. Results: The mean levels of MIF were significantly high-er in both early-onset (169.11±51.88ng/ml) and late-onset (150.6±57.43ng/ml) neonatal sepsis groups, in comparison with the non-septic group (41.97±17.5ng/ml, p-value=0.000). The two groups with sepsisexhibited comparable MIF values. A cutoffvalue >66.7ng/ml for MIF levels was determined to dis-criminate between septic and non-septic neonates with (100% sensitivity; 96.87% specificity; positive predictive value: 97%; negative predictive value: 100%; AUC: 0.997). Furthermore, MIF levels were negatively correlated with absolute lympho-cytic count, PH level in early-onset and random blood glucose in late-onset neonatal sepsis groups. Conclusion: MIF could be an excellent and early diagnos-tic marker for NS even in preterm neonates. Further studies are needed to correlate MIF levels with severity of neonatal sep-sis and compare the diagnostic and prognostic utility of Mac-rophage Migration Inhibitory Factor with other inflammatory biomarkers, like procalcitonin and C-Reactive Protein (CRP).

The Medical Journal of Cairo University/˜The œMedical Journal of Cairo UniversityVol. 93(03)
South Valley University (EG)
Openalex Percentile: Top 90%
Macrophage Migration Inhibitory Factor
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.